116 related articles for article (PubMed ID: 27496532)
1. Metastatic potential to regional lymph nodes with Gleason score ≤7, including tertiary pattern 5, at radical prostatectomy.
Diolombi ML; Epstein JI
BJU Int; 2017 Jun; 119(6):872-878. PubMed ID: 27496532
[TBL] [Abstract][Full Text] [Related]
2. Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy.
Seyrek N; Hollemans E; Andrinopoulou ER; Osanto S; Pelger RCM; van der Poel HG; Bekers E; Remmers S; Schoots IG; van Leenders GJLH
Virchows Arch; 2022 Jun; 480(6):1149-1157. PubMed ID: 35157140
[TBL] [Abstract][Full Text] [Related]
3. Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohort.
Kato M; Shiota M; Kimura T; Hanazawa R; Hirakawa A; Takamatsu D; Tashiro K; Matsui Y; Hashine K; Saito R; Yokomizo A; Yamamoto Y; Narita S; Hashimoto K; Matsumoto H; Akamatsu S; Nishiyama N; Eto M; Kitamura H; Tsuzuki T;
Int J Urol; 2024 Jun; 31(6):662-669. PubMed ID: 38424729
[TBL] [Abstract][Full Text] [Related]
4. Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification.
Greenland NY; Cooperberg MR; Carroll PR; Cowan JE; Simko JP; Stohr BA; Chan E
Prostate; 2024 May; ():. PubMed ID: 38734990
[TBL] [Abstract][Full Text] [Related]
5. Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcome.
Kretschmer A; Tutrone R; Alter J; Berg E; Fischer C; Kumar S; Torkler P; Tadigotla V; Donovan M; Sant G; Skog J; Noerholm M
World J Urol; 2022 Apr; 40(4):983-989. PubMed ID: 35084544
[TBL] [Abstract][Full Text] [Related]
6. Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients.
Samaratunga H; Egevad L; Yaxley J; Perry-Keene J; Le Fevre I; Kench J; Matsika A; Bostwick D; Iczkowski K; Delahunt B
Pathology; 2024 Feb; 56(1):33-38. PubMed ID: 38071161
[TBL] [Abstract][Full Text] [Related]
7. Long term evaluation of optimized Gleason grading in a large cohort of men with prostate cancer in Canada.
Wissing M; Brimo F; McKercher G; Scarlata E; Saad F; Carmel M; Lacombe L; Têtu B; Ekindi-Ndongo N; Latour M; Trudel D; Chevalier S; Aprikian A
Hum Pathol; 2024 Apr; 146():66-74. PubMed ID: 38608782
[TBL] [Abstract][Full Text] [Related]
8. Risk of Biochemical Recurrence in Patients With Grade Group 1 Prostate Cancer With Extraprostatic Extension Treated With Radical Prostatectomy.
Rezaee ME; Pallauf M; Fletcher SA; Han M; Pavlovich CP; Cornelia Ding CK; Epstein JI; Allaf ME; Trock BJ; Singla N
J Urol; 2024 Mar; 211(3):407-414. PubMed ID: 38109699
[TBL] [Abstract][Full Text] [Related]
9. Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.
Chan E; McKenney JK; Hawley S; Corrigan D; Auman H; Newcomb LF; Boyer HD; Carroll PR; Cooperberg MR; Klein E; Fazli L; Gleave ME; Hurtado-Coll A; Simko JP; Nelson PS; Thompson IM; Tretiakova MS; Troyer D; True LD; Vakar-Lopez F; Lin DW; Brooks JD; Feng Z; Nguyen JK
Mod Pathol; 2022 Aug; 35(8):1092-1100. PubMed ID: 35145197
[TBL] [Abstract][Full Text] [Related]
10. Significance of tertiary Gleason pattern 5 in patients with Gleason score 7 after radical prostatectomy: a retrospective cohort study.
Li J; Guo Y; Qiu S; He M; Jin K; Zheng X; Tu X; Liao X; Yang L; Wei Q
Onco Targets Ther; 2019; 12():7157-7164. PubMed ID: 31564900
[TBL] [Abstract][Full Text] [Related]
11. A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancer.
Hesterberg AB; Rios BL; Wolf EM; Tubbs C; Wong HY; Schaffer KR; Lotan TL; Giannico GA; Gordetsky JB; Hurley PJ
J Pathol Clin Res; 2021 May; 7(3):271-286. PubMed ID: 33600062
[TBL] [Abstract][Full Text] [Related]
12. Can Anterior Prostatic Fat Harbor Prostate Cancer Metastasis? A Prospective Cohort Study.
Hosny M; Rai B; Aljaafari F; Agarwal S; McNicholas T; Boustead G; Lane T; Adshead J; Vasdev N
Curr Urol; 2017 Nov; 10(4):182-185. PubMed ID: 29234260
[TBL] [Abstract][Full Text] [Related]
13. Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis.
Singhal U; Nallandhighal S; Tosoian JJ; Hu K; Pham TM; Stangl-Kremser J; Liu CJ; Karim R; Plouffe KR; Morgan TM; Cieslik M; Lucianò R; Shariat SF; Finocchio N; Dambrosio L; Doglioni C; Chinnaiyan AM; Tomlins SA; Briganti A; Palapattu GS; Udager AM; Salami SS
Nat Commun; 2024 May; 15(1):4341. PubMed ID: 38773085
[TBL] [Abstract][Full Text] [Related]
14. Proteomic-based stratification of intermediate-risk prostate cancer patients.
Zhong Q; Sun R; Aref AT; Noor Z; Anees A; Zhu Y; Lucas N; Poulos RC; Lyu M; Zhu T; Chen GB; Wang Y; Ding X; Rutishauser D; Rupp NJ; Rueschoff JH; Poyet C; Hermanns T; Fankhauser C; Rodríguez Martínez M; Shao W; Buljan M; Neumann JF; Beyer A; Hains PG; Reddel RR; Robinson PJ; Aebersold R; Guo T; Wild PJ
Life Sci Alliance; 2024 Feb; 7(2):. PubMed ID: 38052461
[TBL] [Abstract][Full Text] [Related]
15. MRI-Targeted Prostate Biopsy Introduces Grade Inflation and Overtreatment.
Batouche AO; Czeizler E; Lehto TP; Erickson A; Shadbahr T; Laajala TD; Pohjonen J; Vickers AJ; Mirtti T; Rannikko AS
medRxiv; 2024 Jan; ():. PubMed ID: 38260466
[TBL] [Abstract][Full Text] [Related]
16. Genetic ancestry and radical prostatectomy findings in Hispanic/Latino patients.
Acosta-Vega NL; Varela R; Mesa JA; Garai J; Gómez-Gutiérrez A; Serrano-Gómez SJ; Zabaleta J; Sanabria-Salas MC; Combita AL
Front Oncol; 2024; 14():1338250. PubMed ID: 38634046
[TBL] [Abstract][Full Text] [Related]
17. Point-Counterpoint: What's in a Name? Cancer by Any Other Name Is Still Cancer: The Flawed Argument for Renaming Grade Group 1/Gleason Score 3+3=6 Disease.
Kryvenko ON; Gonzalgo ML
J Urol; 2023 Jul; 210(1):28-29. PubMed ID: 37126405
[No Abstract] [Full Text] [Related]
18. How To Report the Minor Component of a High-grade Pattern in Radical Prostatectomy Specimens: Time To Abandon the "Tertiary" Terminology?
Cimadamore A; Giannarini G; Crestani A; Lopez-Beltran A; Montironi R; Cheng L
Eur Urol; 2024 Mar; ():. PubMed ID: 38548491
[TBL] [Abstract][Full Text] [Related]
19. Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial.
Alumkal JJ; Chowdhury S; Loriot Y; Sternberg CN; de Bono JS; Tombal B; Carles J; Flaig TW; Dorff TB; Phung D; Forer D; Noonberg SB; Mansbach H; Beer TM; Higano CS
Clin Genitourin Cancer; 2017 Oct; 15(5):610-617.e3. PubMed ID: 28344102
[TBL] [Abstract][Full Text] [Related]
20. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum.
Secco GB; Fardelli R; Campora E; Lapertosa G; Gentile R; Zoli S; Prior C
Oncology; 1994; 51(1):30-4. PubMed ID: 8265100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
